We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current DVAX market cap is 1.52B. The company's latest EPS is USD -0.0489 and P/E is -238.24.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 167.74M | 184.49M | 46.93M | 60.25M | 69.51M |
| Operating Income | 61.4M | 63.14M | -17.94M | -3.41M | 4.12M |
| Net Income | 65.81M | 67.45M | -24.33M | 3.43M | 14.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35.22M | 46.55M | 439.44M | 722.68M | 232.28M |
| Operating Income | -134.84M | -75.22M | 133.49M | 282.52M | -25.72M |
| Net Income | -155.87M | -75.24M | 72.14M | 292.87M | -6.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 999.34M | 985.85M | 969.92M | 936.43M | 972.93M |
| Total Liabilities | 498.76M | 404.84M | 406.19M | 359.23M | 368.02M |
| Total Equity | 500.58M | 581.01M | 563.73M | 577.21M | 604.92M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 279.07M | 353.27M | 1.04B | 985.85M | 997.1M |
| Total Liabilities | 270.78M | 294.58M | 816.87M | 404.84M | 375.02M |
| Total Equity | 8.29M | 58.69M | 222.37M | 581.01M | 622.07M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 27.77M | 62.72M | 27.62M | 55.67M | 86.8M |
| Investing | -283.03M | -316M | -52.33M | -27.61M | -133.69M |
| Financing | 19.37M | 19.53M | -3.09M | -3.38M | -390k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -121.25M | -92.25M | 335.53M | 62.72M | 100.56M |
| Investing | -42.78M | -26.53M | 14.23M | -316M | -153.93M |
| Financing | 154.35M | 109.5M | 55.78M | 19.53M | 1.39M |
| Market Cap | 1.52B |
| Price to Earnings Ratio | -238.24 |
| Price to Sales Ratio | 6.55 |
| Price to Cash Ratio | 10.13 |
| Price to Book Ratio | 2.45 |
| Dividend Yield | - |
| Shares Outstanding | 130.61M |
| Average Volume (1 week) | 2.11M |
| Average Volume (1 Month) | 1.52M |
| 52 Week Change | 6.72% |
| 52 Week High | 15.15 |
| 52 Week Low | 10.06 |
| Spread (Intraday) | 0.01 (0.09%) |
| Company Name | Dynavax Technologies Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.dynavax.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
